DMRF Welcomes Allergan, an AbbVie Company as Returning National Sponsor of Dystonia Zoo Days

Logo that reads Dystonia Zoo Day 2022 with animal figures.Allergan, an AbbVie Company is continuing their long-standing support of the dystonia community by returning as a National Sponsor of the Dystonia Medical Research Foundation’s (DMRF) Dystonia Zoo Days in 2022. The purpose of these events is to bring together individuals and families affected by dystonia and raise funds in support of the DMRF mission.

A Virtual Kick-Off Celebration will launch the Dystonia Zoo Day season on August 18th. Eight cities will host an in-person Dystonia Zoo Day: Portland (8/20), Toledo (8/27), NYC/Bronx (9/10), Boston (9/17), Pittsburgh (9/18), Cleveland (9/25), Los Angeles (10/1), and Twin Cities (10/2).

The event series will end with the 3rd Virtual Dystonia Zoo Day & Closing Ceremony on October 8th.

“Allergan, an AbbVie Company has a long history of partnerships with the DMRF, for which we are grateful,” said Mark Rudolph, President of the DMRF. “Dystonia Zoo Days are special events because they foster a sense of community among individuals with dystonia and their families as well as increase dystonia awareness—all in a fun and celebratory atmosphere.”

Dystonia is a chronic, often disabling, neurological disorder marked by excessive, involuntary muscle contractions that cause abnormal body motions and postures. Estimates suggest dystonia affects 250,000 Americans of all ages. Common signs include abnormal neck movements, excessive blinking, a breathy or strangled-sounding voice, muscle contractions and tightness in the hand, and/or a twisted foot. Although there is no cure yet, treatment options are available.


The Dystonia Medical Research Foundation is a 501(c)(3) non-profit organization dedicated to advancing research for improved dystonia treatments and ultimately a cure, promoting awareness, and supporting the well-being of affected individuals and families.